Effectiveness of an online insomnia program (SHUTi) for prevention of depressive episodes (the GoodNight Study): a randomised controlled trial
- PMID: 26827250
- DOI: 10.1016/S2215-0366(15)00536-2
Effectiveness of an online insomnia program (SHUTi) for prevention of depressive episodes (the GoodNight Study): a randomised controlled trial
Erratum in
-
Corrections.Lancet Psychiatry. 2016 Apr;3(4):320. doi: 10.1016/S2215-0366(16)30003-7. Lancet Psychiatry. 2016. PMID: 27063380 No abstract available.
Abstract
Background: In view of the high co-occurrence of depression and insomnia, a novel way to reduce the risk of escalating depression might be to offer an insomnia intervention. We aimed to assess whether an online self-help insomnia program could reduce depression symptoms.
Methods: We did this randomised controlled trial at the Australian National University in Canberra, Australia. Internet users (aged 18-64 years) with insomnia and depression symptoms, but who did not meet criteria for major depressive disorder, were randomly assigned (1:1), via computer-generated randomisation, to receive SHUTi, a 6 week, modular, online insomnia program based on cognitive behavioural therapy for insomnia, or HealthWatch, an interactive, attention-matched, internet-based placebo control program. Randomisation was stratified by age and sex. Telephone-based interviewers, statisticians, and chief investigators were masked to group allocation. The primary outcome was depression symptoms at 6 months, as measured with the Patient Health Questionnaire (PHQ-9). The primary analysis was by intention to treat. This trial is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12611000121965.
Findings: Between April 30, 2013, and June 9, 2014, we randomly assigned 1149 participants to receive SHUTi (n=574) or HealthWatch (n=575), of whom 581 (51%) participants completed the study program assessments at 6 weeks and 504 (44%) participants completed 6 months' follow-up. SHUTi significantly lowered depression symptoms on the PHQ-9 at 6 weeks and 6 months compared with HealthWatch (F[degrees of freedom 2,640·1]=37·2, p<0·0001). Major depressive disorder was diagnosed in 22 (4%) participants at 6 months (n=9 in the SHUTi group and n=13 in the HealthWatch group), with no superior effect of SHUTi versus HealthWatch (Fisher's exact test=0·52; p=0·32). No adverse events were reported.
Interpretation: Online cognitive behaviour therapy for insomnia treatment is a practical and effective way to reduce depression symptoms and could be capable of reducing depression at the population level by use of a fully automatised system with the potential for wide dissemination.
Funding: Australian National Health and Medical Research Council.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Comment in
-
Prevention of depression worldwide: a wake-up call.Lancet Psychiatry. 2016 Apr;3(4):306-7. doi: 10.1016/S2215-0366(15)00555-6. Epub 2016 Jan 28. Lancet Psychiatry. 2016. PMID: 26827251 No abstract available.
Similar articles
-
The GoodNight study--online CBT for insomnia for the indicated prevention of depression: study protocol for a randomised controlled trial.Trials. 2014 Feb 13;15:56. doi: 10.1186/1745-6215-15-56. Trials. 2014. PMID: 24524214 Free PMC article.
-
Online insomnia treatment and the reduction of anxiety symptoms as a secondary outcome in a randomised controlled trial: The role of cognitive-behavioural factors.Aust N Z J Psychiatry. 2018 Dec;52(12):1183-1193. doi: 10.1177/0004867418772338. Epub 2018 May 2. Aust N Z J Psychiatry. 2018. PMID: 29717621 Clinical Trial.
-
Internet-based behavioural activation with lay counsellor support versus online minimal psychoeducation without support for treatment of depression: a randomised controlled trial in Indonesia.Lancet Psychiatry. 2018 Sep;5(9):707-716. doi: 10.1016/S2215-0366(18)30223-2. Epub 2018 Jul 11. Lancet Psychiatry. 2018. PMID: 30006262 Clinical Trial.
-
Effect of a Web-Based Cognitive Behavior Therapy for Insomnia Intervention With 1-Year Follow-up: A Randomized Clinical Trial.JAMA Psychiatry. 2017 Jan 1;74(1):68-75. doi: 10.1001/jamapsychiatry.2016.3249. JAMA Psychiatry. 2017. PMID: 27902836 Clinical Trial.
-
Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies.J Affect Disord. 2011 Dec;135(1-3):10-9. doi: 10.1016/j.jad.2011.01.011. Epub 2011 Feb 5. J Affect Disord. 2011. PMID: 21300408 Review.
Cited by
-
Effect of a prescription digital therapeutic for chronic insomnia on post-treatment insomnia severity, depression, and anxiety symptoms: results from the real-world DREAM study.Front Psychiatry. 2024 Sep 10;15:1450615. doi: 10.3389/fpsyt.2024.1450615. eCollection 2024. Front Psychiatry. 2024. PMID: 39319356 Free PMC article.
-
Effectiveness of a guided digital self-help intervention to improve sleep and the biological clock in university students - Study protocol for a randomized controlled trial.Internet Interv. 2024 Aug 2;37:100763. doi: 10.1016/j.invent.2024.100763. eCollection 2024 Sep. Internet Interv. 2024. PMID: 39224668 Free PMC article.
-
Nurse-delivered sleep restriction therapy to improve insomnia disorder in primary care: the HABIT RCT.Health Technol Assess. 2024 Aug;28(36):1-107. doi: 10.3310/RJYT4275. Health Technol Assess. 2024. PMID: 39185919 Free PMC article. Clinical Trial.
-
Effectiveness of digital Cognitive-Behavioural Therapy for Insomnia in patients with musculoskeletal complaints and insomnia in primary care physiotherapy: study protocol for a randomised controlled trial.BMJ Open. 2024 Aug 21;14(8):e083592. doi: 10.1136/bmjopen-2023-083592. BMJ Open. 2024. PMID: 39174064 Free PMC article.
-
Evaluating the Efficacy of a Digital Therapeutic (CT-152) as an Adjunct to Antidepressant Treatment in Adults With Major Depressive Disorder: Protocol for the MIRAI Remote Study.JMIR Res Protoc. 2024 Aug 20;13:e56960. doi: 10.2196/56960. JMIR Res Protoc. 2024. PMID: 39163592 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
